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ABSTRACT
Background Submicroscopic deletions in 14q12
spanning FOXG1 or intragenic mutations have been
reported in patients with a developmental disorder
described as a congenital variant of Rett syndrome. This
study aimed to further characterise and delineate the
phenotype of FOXG1 mutation positive patients.
Method The study mapped the breakpoints of a 2;14
translocation by fluorescence in situ hybridisation and
analysed three chromosome rearrangements in 14q12 by
cytogenetic analysis and/or array comparative genomic
hybridisation. The FOXG1 gene was sequenced in 210
patients, including 129 patients with unexplained
developmental disorders and 81 MECP2 mutation
negative individuals.
Results One known mutation, seen in two patients, and
nine novel mutations of FOXG1 including two deletions,
two chromosome rearrangements disrupting or displacing
putative cis-regulatory elements from FOXG1, and seven
sequence changes, are reported. Analysis of 11 patients
in this study, and a further 15 patients reported in the
literature, demonstrates a complex constellation of
features including mild postnatal growth deficiency,
severe postnatal microcephaly, severe mental retardation
with absent language development, deficient social
reciprocity resembling autism, combined stereotypies and
frank dyskinesias, epilepsy, poor sleep patterns, irritability
in infancy, unexplained episodes of crying, recurrent
aspiration, and gastro-oesophageal reflux. Brain imaging
studies reveal simplified gyral pattern and reduced white
matter volume in the frontal lobes, corpus callosum
hypogenesis, and variable mild frontal pachgyria.
Conclusions These findings have significantly expanded
the number of FOXG1mutations and identified two affecting
possible cis-regulatory elements. While the phenotype of
the patients overlaps both classic and congenital Rett
syndrome, extensive clinical evaluation demonstrates
a distinctive and clinically recognisable phenotype which
the authors suggest designating as the FOXG1 syndrome.
INTRODUCTION
Recently, a series of reports have implicated dele-
tions or sequence alterations of FOXG1 as the cause
of a developmental disorder described as a congenital
variant of Rett syndrome (RTT; MIM 312750).
Small de novo interstitial deletions in 14q12 were
detected by chromosome microarrays in four child-
ren1e4 and a complex chromosome rearrangement
consisting of a translocation and adjacent small
inversion in another patient.5 The common deleted
region includes the telomeric breakpoint of the
inversion in the latter patient and contains FOXG1,
a strong candidate gene based on high and speciﬁc
expression in developing brain and complex
malformations of the telencephalon in both homo-
zygous and heterozygous mouse mutants.6e8
Subsequently, sequencing of FOXG1 in ﬁve small
cohorts of patients with overlapping phenotypes
but negative results forMECP2 testing identiﬁed 11
patients with intragenic mutations including ﬁve
nonsense, four frameshift, and two missense
mutations.9e13 Common clinical features in all
these children included decelerating head circum-
ference from 3 months that resulted in severe
postnatal microcephaly, severe mental retardation
with absent language, apraxia, jerky movements,
and generalised seizures. Brain imaging in several
patients revealed hypogenesis of the corpus
callosum.9 10 12 The phenotype was interpreted as
resembling Rett syndrome except for no early
period of normal development, which we view as
one of several signiﬁcant differences. Recently,
duplications of FOXG1 have been associated with
developmental epilepsy, mental retardation, and
severe speech impairment in eight patients.14 15
After mapping a de novo chromosome trans-
location found in a severely mentally retarded girl
to this region, we became interested in the types of
mutations involving FOXG1 and the nature of the
associated developmental disorder. Is the pheno-
type accurately described as a congenital variant of
Rett syndrome, or is it a speciﬁc and recognisable
syndrome in its own right? Here we report two
microdeletions, two chromosome rearrangements
most likely causing dysregulated FOXG1 expres-
sion, and seven intragenic sequence changes among
210 patients tested. This cohort includes 129
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Figure 1 Brain imaging in a normal 3-year-old girl (AeD) and four patients with FOXG1 mutations (EeT). Here and in figure 2, each row shows four
images from the same patient. The columns contain midline sagittal (left column) and parasagittal (second column) images, and axial images through
the lateral ventricles (third column) and high convexity (right column). All four patients have a low forehead that reflects underlying microcephaly,
foreshortened frontal lobes and reduced white matter volume that appears severe in the frontal lobes (asterisks in 12/16 images) and subtle in posterior
J Med Genet 2011;48:396e406. doi:10.1136/jmg.2010.087528 397
Phenotypes
group.bmj.com on August 30, 2017 - Published by http://jmg.bmj.com/Downloaded from 
patients referred to us directly because of unexplained develop-
mental disorders, and 81 ascertained following negative testing
for MECP2.
Our data and review of prior reports conﬁrm mutations or
dysregulation of FOXG1 as the cause of the developmental
phenotype, which differs from classic Rett syndrome and other
so-called Rett variants based on a speciﬁc and recognisable
combination of developmental and brain imaging features. We
prefer to designate this as the FOXG1 syndrome, which has
overlapping features with a rapidly growing group of develop-
mental encephalopathies that already includes Angelman
(UBE3A associated), Rett (MECP2 associated), PitteHopkins




We obtained clinical data, brain imaging studies and results of
laboratory testing, as well as blood or DNA samples, from 129
patients with mental retardation, microcephaly, frontal pachy-
gyria or hypogenesis of the corpus callosum who were assessed
by experienced clinical geneticists or neurologists. Two patients
were recruited through the MRNET consortium (http://www.
german-mrnet.de). We received 81 DNA samples from patients
tested in a diagnostic lab for MECP2 and found to be negative.
All available brain imaging studies from patients with a FOXG1
mutation were interpreted by one of the authors (WBD) with
selected images shown in ﬁgures 1 and 2. The clinical data and
samples were obtained with informed consent, including
consent to use the photographs and videos in this report, under
protocols approved by Institutional Review Boards at all
participating institutions.
Fluorescence in situ hybridisation
Metaphase spreads from peripheral blood lymphocytes were
prepared by standard procedure. Fluorescence in situ hybrid-
isation (FISH) experiments for delineation of the 2q11.2 and
14q12 breakpoints were performed with bacterial artiﬁcial
chromosome (BAC) and fosmid clones. FISH with BAC clones
was also performed to conﬁrm array comparative genomic
hybridisation (CGH) and molecular karyotyping data. BACs
(RP11 Human BAC Library) were obtained from the Resource
Center for Genome Research at the Max-Planck-Institute for
Molecular Genetics, Berlin, Germany, or the BACPAC Resource
Center, Children’s Hospital Oakland, California, USA. Fosmid
clones (WIBR-2 Human Fosmid Library (G248P8)) were received
from the BACPAC Resource Center, Children’s Hospital. BAC
and fosmid DNAwas prepared using the NucleoBond Xtra Midi
kit (Machery-Nagel, Düren, Germany) or the Qiagen Large-
Construct kit (Qiagen, Hilden, Germany). DNA was labelled by
nick translation using the CGH Nick Translation Kit and Spec-
trum Green-dUTP (Vysis, Downers Grove, Illinois, USA)
according to the protocol provided. Chromosomes were coun-
terstained using 4’,6-diamidino-2-phenylindole (DAPI) (Serva
Feinbiochemica, Heidelberg, Germany) and mounted in anti-
fading solution (Vector Labs, Burlingame, California, USA).
Slides were analysed with a Leica Axioscope ﬂuorescence
microscope. Images were merged using a cooled CCD camera
(Pieper, Schwerte, Germany) and Cyto Vision software (Applied
Imaging, San Jose, California, USA).
Molecular karyotyping and array CGH
Molecular karyotyping using the Affymetrix Mapping Gene-
Chip 250 K Mapping SNP-Array (Nsp) (Affymetrix, Santa Clara,
California, USA) was performed in patient 3 according to the
supplier ’s instructions. Data were analysed using Nexus and
CNVF2.2 software.23 Array CGH in patient 4 was performed
using a whole genome oligonucleotide array (244K, Agilent
Technologies, Santa Clara, California, USA). 244K image data
were analysed using Feature Extraction 9.5.3.1 and CGH
Analytics 3.4.40 software (Agilent) with the following analysis
settings: aberration algorithm ADM-2; threshold: 6.0; window
size: 0.2 Mb; ﬁlter: 5probes, log2ratio¼0.29.
Mutation analysis
We ampliﬁed the coding region of the FOXG1 gene (1 exon;
GenBank accession no. NM_005249) from genomic DNA with
ﬁve primer pairs that yielded overlapping amplicons. Primer
sequences are available on request. Amplicons were directly
sequenced using the ABI BigDye Terminator Sequencing Kit
(Applied Biosystems) and an automated capillary sequencer (ABI
3130; Applied Biosystems). Sequence electropherograms were
analysed using Sequence Pilot software (JSI medical systems,
Kippenheim, Germany). Where mutations were shown to have
arisen de novo, we veriﬁed self-reported relationships by geno-
typing both parents and the patient at 10 microsatellite loci.
RESULTS
Mapping of the chromosomal breakpoint in 14q12 by FISH
Patient 1, a 12-year-old girl, was referred at 7 years because of
severe mental retardation and postnatal microcephaly. She is the
fourth child of healthy parents and her three older sisters are
healthy. She was born at 40 weeks gestation by natural delivery
with a birth weight 3350 g (0 SD), length 51 cm (0 SD), and
occipitofrontal circumference (OFC) 32.5 cm (e1 SD). At
6 months, she was able to turn, but she has never been able to sit
or stand. She did not react to visual and acoustic stimuli in
infancy, but this improved at later ages. Ophthalmologic
examination revealed convergent strabismus. At 7 months she
developed seizures. An electroencephalogram (EEG) revealed
spikes and sharp waves over the left centroparietal and both
centrotemporal regions. She could speak single words at 1 year,
but lost this ability by 2 years. She had gastro-oesophageal reﬂux
and constipation. Her brain MRI demonstrated a strikingly
reduced volume of white matter in the anterior frontal lobes
with mildly thick cortex, striking hypoplasia and dysplasia of
the anterior corpus callosum resembling a sharp hook, and
probably dysplastic hippocampus (ﬁgure 1EeH).
[Continued]
regions. All four have hypogenesis of the anterior corpus callosum with a ‘pointed hook’ appearance in three of them (arrows in E, M, Q) that consists
of striking narrowing of the anterior body, genu and rostrum with the tiny rostrum forming a pointed tip, and relatively normal posterior callosum. In the
remaining patient (arrow in I), the entire body of the corpus callosum is narrow and the genu small but less so than the others, leaving it dysmorphic
but different from the ‘pointed hook’ appearance. Three patients have subtle pachygyria over the frontal lobes only that consists of mildly short and
wide gyri and mildly thick cortex (arrowheads in FeH, JeL, NeP), a subtle abnormality that may be accentuated by the reduced volume of the white
matter. The increased cortical thickness was not seen in the remaining patients (ReT and figure 2). Also, three patients had mildly enlarged lateral
ventricles, with one having an abnormally narrow anterior body and frontal horns (S). These images come from patients 1 (EeH), 5 (IeL), 7 (MeP) and
9 (QeT), and a normal control (AeD).
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Figure 2 Brain imaging in another six patients with FOXG1 mutations. Five have mildly enlarged lateral ventricles. The patients in the top four rows
have changes similar to those seen in figure 1, including microcephaly (E, I, M: not obvious in A, Q, U), short frontal lobes and reduced volume of
frontal white matter (asterisks in 9 images). Hypogenesis of the corpus callosum was seen in 4/6 (arrows in A, E, I, M), but with different patterns. The
first patient (A) has a thin and dysmorphic corpus callosum similar to figure 1I, the next total agenesis of the corpus callosum (E), and the third and
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Prenatal chromosome analysis revealed an apparently balanced
chromosome translocation: 46,XX,t(2;14)(q13;q13). Chromo-
some analysis was normal in both parents, indicating that it
occurred de novo (paternity conﬁrmed). FISH analysis with
fosmid G248P81425A7 from chromosome 2 identiﬁed signals on
2q11.2 as well as the der(2) and der(14), indicating that this
clone spanned the breakpoint (data not shown). No gene was
directly disrupted by the breakpoint, although INPP4A is located
5e10 kb telomeric to the breakpoint (data not shown). A 1-bp
deletion in Inpp4a encoding inositol polyphosphate 4-phospha-
tase type I occurred in the spontaneous weeble mouse mutant,
which has severe locomotor instability and signiﬁcant neuronal
loss in the cerebellum and hippocampal CA1 sector.24 Patient 1 is
heterozygous for the breakpoint close to INPP4A, and further
the weeble phenotype is a recessive condition that differs
signiﬁcantly from the phenotype in this girl.24
We therefore ﬁne-mapped the 14q breakpoint, ﬁnding fosmid
probes that hybridised proximal (F-4069H4) and distal
(F-2653A9) to the breakpoint, as well as a single fosmid clone
that spanned the breakpoint (F-9677B10, ﬁgure 3A). We
narrowed the breakpoint to aw10 kb gene-poor region in 14q12
located w265 kb downstream of FOXG1 (ﬁgure 3A), suggesting
that a position effect could cause transcriptional misregulation
of this gene. In silico analysis using the Regulatory Potential
score identiﬁed several candidate cis-regulatory elements that are
evolutionarily conserved throughout a 1 Mb region downstream
of FOXG1 (ﬁgure 3C). Two of these non-coding elements located
at genomic positions chr14:28,930,280-28,932,099 and
chr14:28,754,647-28,756,495 (NCBI Build 36.1; ﬁgure 3C) have
been analysed for gene enhancer activity as assessed in trans-
genic mice. Both DNA sequence elements are evolutionarily
highly conserved and were found to drive expression of
a reporter gene (lacZ) in mouse forebrain (http://enhancer.lbl.
gov/frnt_page.shtml). These data suggest that translocation of
either or both of these putative cis-regulatory elements to
chromosome 2 may have caused dysregulated expression of
FOXG1 in the translocation patient.
Identification of deletions in 14q12 by cytogenetic and array CGH
analysis
Patient 2 presented with developmental delay, slow head
growth, and severe feeding problems. Brain MRI showed a short
corpus callosum (ﬁgure 2MeP). Routine chromosome analysis
revealed a de novo deletion in chromosome 14 (46,XX,del(14)
(q13.1q13.2)). We conﬁrmed the deletion by FISH with two BAC
clones, RP11-412H8 and RP11-148E7, ﬂanking FOXG1 as well as
BAC RP11-330O19 hybridising proximal and RP11-908D14 and
RP11-116N8 hybridising distal to the deletion, respectively (data
not shown and ﬁgure 3B). We estimate the maximum size of the
deletion as w8.4 Mb in 14q12-q13.1 including FOXG1.
[Continued]
fourth partial agenesis with a short and thin corpus callosum (I, M). No patients in this group have pachygyria. The last two patients have normal brain
imaging except for subtle reduced volume of the frontal white matter and mildly simplified gyral pattern. These images come from patients 6 (AeD), 3
(EeH), 2 (IeL), 10 (MeP), 4 (QeT), and 11 (UeX).
Figure 3 Deletions including FOXG1
and regulatory mutations. (A) Physical
map of the 14q12-q13.1 region. Genes
in this region are represented by arrows
indicating the 59/39 orientation.
Fosmid clones (F- (G248P8); WIBR-2
Human Fosmid Library) used for
mapping the 14q12 breakpoint of the
2;14 translocation in patient 1 (1) are
indicated by coloured bars and names
are given. Colour code of fosmids;
black: mapped distal to the
translocation breakpoint; blue: spanned
the breakpoint; green: mapped proximal
to breakpoint. The breakpoint region is
indicated by a wavy vertical arrow in
red. (B) Deletions in 14q12. Horizontal
black lines depict the deletions
identified in patients 2e4 (2, 3, 4).
Arrowheads at the left and right side of
the deletion in patient 2 show that this
deletion extends to either side. Dotted
lines indicate that the respective
deletion breakpoints have not been
fine-mapped. Bacterial artificial
chromosome (BAC) clones (RP11
Human BAC Library) used for
fluorescence in situ hybridisation (FISH)
analysis to confirm the presence of the
deletions in the patients are indicated
by red bars and names are given.
(C) A detailed view of the region containing putative long range cis-regulatory elements of FOXG1. In the upper part, the two black vertical bars
represent potential regulatory elements (genomic positions chr14:28,754,647e28,756,495 bp and 28,930,280e28,932,099 bp) that have been
identified with the ESPERR (evolutionary and sequence pattern extraction through reduced representations) computational method. In the lower part,
a more detailed view of the region of high regulatory potential (RP) values, with the UCSC genome browser map of seven-way (human, chimpanzee,
macaque, mouse, rat, dog, and cow; March 2006 assembly) RP analysis of the candidate cis-regulatory elements distal to FOXG1.
400 J Med Genet 2011;48:396e406. doi:10.1136/jmg.2010.087528
Phenotypes
group.bmj.com on August 30, 2017 - Published by http://jmg.bmj.com/Downloaded from 
Genome-wide array CGH was performed on a clinical basis on
two patients with postnatal microcephaly and severe mental
retardation. We detected a w5.4 Mb heterozygous deletion in
14q12-q13.1 in patient 3 that encompasses at least 13 genes
including FOXG1, and conﬁrmed the deletion by FISH with BAC
clone RP11-329K12 (ﬁgure 3B and data not shown). Neither
parent carried the deletion (data not shown; paternity
conﬁrmed). We identiﬁed a w1.09 Mb microdeletion down-
stream of FOXG1 in patient 4 that removes a large part of the
next gene, PRKD1. PRKD1 encodes protein kinase D1 (also
known as PKD or PKD1), a serine/threonine kinase that regu-
lates a variety of cellular functions, including membrane
receptor signalling, transport processes, protection from oxida-
tive stress, transcriptional regulation, and F-actin reorganisa-
tion.25 26 FISH with BAC clones RP11-30H9 and RP11-419C10
yielded only one signal on metaphase spreads, whereas two
signals were obtained on metaphase spreads of his parents
(ﬁgure 3B and data not shown; paternity conﬁrmed). By quan-
titative PCR we conﬁrmed the presence of two copies of the
FOXG1 gene in patient 4 (data not shown), suggesting that
similar to patient 1 a position effect might have caused altered
expression of FOXG1. In line with this ﬁnding, the deletion
spans the two putative long range cis-regulatory elements for
FOXG1 expression (ﬁgure 3C).
Sequence analysis of FOXG1
We next selected 125 patients with phenotypes overlapping
patients 1e4, including mental retardation, postnatal micro-
cephaly, mild frontal pachygyria, and callosal abnormalities. We
sequenced FOXG1 in this cohort, and detected four intragenic
mutations in the heterozygous state, including the transitions
c.757A/G (p.N253D) in patient 5 and c.700T/C (p.S234P) in
patient 11, the frameshift mutation c.460dupG (p.E154GfsX301)
in patient 6, and the nonsense mutation c.256C/T (p.R86X) in
patient 9. The missense mutations affect invariant amino acids,
asparagine at position 253 and serine at position 234. Both
residues are located in the DNA binding (forkhead) domain of
FOXG1, suggesting that these amino acid exchanges may alter
DNA binding properties of FOXG1. The c.757A/G mutation
was not detected in the parents of patient 5 or in 204 control
chromosomes. Similarly, the c.700T/C mutation was not
found in the parents of patient 11. The 1 bp duplication was not
identiﬁed in the parents of patient 6 or in 200 alleles, and the
nonsense mutation was absent from the DNA sample of the
mother of patient 9 (the father was deceased). Thus, three of
four intragenic FOXG1 mutations occurred de novo (data not
shown; all parental identities conﬁrmed).
We also sequenced FOXG1 in a cohort of 81 patients (55
females and 26 males) tested for MECP2 mutations in a
diagnostic laboratory with negative results. We detected
the intragenic insertionedeletion mutation c.505_506delGGinsT
(p.G168SfsX23) in patient 7 and the frameshift mutation
c.263_278del16 (p.R88PfsX99) in patient 10, both in the
heterozygous state. The parents of patients 7 and 10 did not
carry the respective mutation (paternity conﬁrmed), which was
not detected in 200 control chromosomes. We also identiﬁed the
same c.460dupG mutation in patient 8 as detected in patient 6.
Sequencing of FOXG1 in patients 1e4 was negative.
Phenotype of the FOXG1 mutation positive patients
We reviewed clinical (table 1) and brain imaging (table 2) data in
all 11 patients, and videotapes in four of the 11 patients
(supplementary videos 1e4). Detailed results are listed
in supplementary table 1 for all patients, and comparable
information is collated for 16 previously reported patients in
supplementary table 2. All of our patients had normal body
measurements at birth with mildly slow growth thereafter
leading to low weight (1.5 to 2.5 SD) and low normal stature
(0 to 2 SD) by 1e2 years. Birth head size was low normal (0 to
2 SD) in 5/7 and borderline small (2 to 3 SD) in 2/7
children. Severe postnatal microcephaly (MIC) was apparent by
2 years (4 to 6 SD) in 6/8 patients.
All 11 patients had early global developmental delay and later
severe mental retardation. Only 3/10 learned to sit indepen-
dently and only 1/11 learned to walk. None developed speech.
All had deﬁcient social interactions, especially poor eye contact.
Several improved enough to allow use of pointing and assistive
communication devices (but not speech), and limited social
interaction. Two children had a history of possible regression,
but this was subtle and difﬁcult to document. The remainder
had no history suggesting regression.
Exams reported muscular hypotonia in 10/10 and spasticity
in 7/9 patients. We found stereotypies especially of the hands in
8/11, and dyskinesias in 8/10 with features of chorea, athetosis
and dystonia. However, we observed dyskinesia in 6/6 patients
reviewed during the course of this study with videos available of
four patients (see supplementary videos 1e4), which suggests
that this may be seen in all patients.
Dysfunction in several vegetative functions was apparent in
all children. Sleep was disrupted from infancy in at least 8/11
children, with frequent night-time waking. This usually
improved with age, or after gastrostomy placement in one child.
Prominent irritability or crying was reported in 6/10 patients,
especially in infancy. Gastro-oesophageal reﬂux was diagnosed in
9/10 children, and was often severe, becoming a prominent part
of the overall phenotype. Aspiration was documented in 6/10. A
gastrostomy tube was recommended for feeding in 2/7 children
but only placed in one.
Seizures were documented in 8/10 patients with onset
between 3 months and 6 years. They consisted of tonic, gener-
alised tonic-clonic, and partial complex seizures. None had
infantile spasms. EEG ﬁndings were variable from reports, but
the original studies were not reviewed. Several other features are
noted in supplementary table 1.
Brain MRI studies were reviewed in all 11 patients (ﬁgures 1
and 2). The forehead was usually low, although this was
subjective. All 11 had a simpliﬁed gyral pattern deﬁned as
a reduced number of gyri separated by shallow sulci, and signif-
icantly reduced volume of white matter that appears most
severedby fardin the frontal lobes. We observed mild frontal
pachygyria in 3/11 patients; our recognition of subtle frontal
pachygyria in patient 1 led directly to testing and detection of an
intragenic mutation in patient 5. We found hypogenesis of the
corpus callosum in 9/11 patients including three with a novel
defect in which the frontal portion of the corpus callosum
narrows to a sharp point or hook, with an absent rostrum and
very small genu (ﬁgure 1E,M,Q). One child with a large 14q12
deletion had complete agenesis of the corpus callosum (ﬁgure 2I).
The remaining patients had a short or thin corpus callosum with
dysmorphic or absent rostrum and narrow or absent splenium.
The two patients with a normal corpus callosum were those
with a 14q12 deletion 35 kb distant from FOXG1 (ﬁgure 2Q) and
the patient with the missense mutation p.S234P (ﬁgure 2U).
The two children with large deletions (patients 2 and 3) had
mild dysmorphic facial features in addition to the MIC,
including wide and round face, ﬂat midface, large ears and small
jaw. The remaining children had obvious MIC with subtle and
non-speciﬁc dysmorphic features (ﬁgure 4).
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DISCUSSION
Foxg1 is a transcription factor that regulates development of the
telencephalon from early embryonic to adult stages by multiple
diverse mechanisms.6 7 27 Not surprisingly, it was recognised as
a strong candidate gene to explain the developmental disorder
associated with deletion 14q12 and as a single gene cause of
human developmental disorders.5 9 Our study extends several
previous reports, demonstrating that heterozygous loss of
FOXG1 results in a consistent and severe developmental
phenotype with emerging genotypeephenotype correlations.
Foxg1 function
Foxg1 is a conserved transcriptional repressor that is strongly
expressed in progenitors of the ventricular zone and early post-
mitotic neurons in the developing neuroepithelium of the
telencephalon and visual structures.28e31 It is involved in the
timing of neuronal differentiation and in the speciﬁcation of
subdomain identity, regulating dorsaleventral and subsequently
rostralelateral regional differentiation and later neural progen-
itor versus Cajal-Retzius cell fate, expansion of the neural
progenitor pool, and progenitor cell cycle length.8 30 32e35
Table 1 Clinical data for patients with deletion 14q12 or FOXG1 mutations
This report N[11 Literature1e5 9e13 N[15
FOXG1 mechanism 4 CYTO, 7 intragenic 5 CYTO, 10 intragenic
Subject demographics
Sex 5 female:6 male 14 female:1 male
Age last follow-up 2 years to 31 years 10 months to 22 years
Growth
Weight birth (%) 10/10 normal (10e90%) 15/15 (10e90%)
Length birth (%) 9/9 normal (10e75%) 14/14 (25e90%)
OFC birth (SD) 5/7 (0 to 2 SD); 2/7 (e2.5 SD) 4/14 (+1 to 0 SD); 10/13 (0 to 2)
Weight age 1e2 years (SD), age 5/6 (1.5 to 2.6 SD); 1/6 25% Insufficient data
Length age 1e2 years (SD), age 5/6 (0 to 2 SD); 1/6 (e3.5 SD) Insufficient data
OFC age 1e2 years (SD), age 8/8 (2.5 to 6 SD) Insufficient data
Weight most recent (SD), age 4/10 (1 to 2 SD); 6/10 (e2 to 5.5 SD) 6/9 (1 to 2 SD); 3/9 (e3 SD)
Length most recent (SD), age 2/8 (1 to 2 SD); 5/8 (e2 to 5 SD) 6/9 (0 to 2 SD); 2/9 (e3.5 to 4)
OFC most recent (SD), age 9/9 (2.5 to 5.5 SD) 12/12 (2 to 5 SD)
Development
Developmental delay (DD) 11/11 DD
Mental retardation (MR) 11/11 MR 15/15 MR
Mental retardation (severity) 11/11 severe 5/5 severe
Speechelanguage development 11/11 no language 13/14 no language
Social interaction (eye contact) 10/10 poor 7/9 poor
Sitting (age) 3/10 sit, all late 3/13 sit
Walking (age) 1/11 walk, late 1/15 walk
Loss of psychomotor skills (age) 2/11 vague history loss skills 8e11 regression
Behaviour, sleep, autonomic
Sleep pattern 8/11 poor sleep pattern 4/8 poor sleep pattern
Irritability 5/10 excess irritability Insufficient data
Crying/weeping (inconsolable) 6/10 excess crying 3/6 excess crying
Laughing (inappropriate) 0/11 excess laughing Insufficient data
Motor and dyskinesias
Hypotonia 10/10 hypotonia 6/6 hypotonia
Spasticity 7/9 spasticity 1/2 insufficient data
Functional hand use 8/11 no hand use 8/10 no hand use
Stereotypic movements 8/11 stereotypies 10/10 stereotypies
Dyskinesias (chorea, dystonia) 8/10 dyskinesia (or all?) 10/10 dyskinesia
Strabismus insufficient data 9/9 strabismus
Bruxism 5/8 bruxism 10/13 bruxism
Drooling (sialorrhea) No data 7/9 drooling
Epilepsy
Seizures (age onset) 8/10 seizures 10/15 seizures (6 months to 14 years)
Seizure types (specify) CPS, FTCS, GTCS CPS, GTCS, myoclonic
Gastrointestinal and respiratory systems
Feeding difficulties 9/11 poor feeding 5/6 poor feeding
Aspiration 6/10 aspiration Insufficient data
Gastro-oesophageal reflux (GER) 9/10 GER often severe 5/5 GER
Constipation Insufficient data 6/6 constipation
Breathing abnormalities Non-specific 3/5 abnormal respirations
Other abnormalities
Facial dysmorphism 2/3 with deletions 4/4 with deletions
Scoliosis Insufficient data 4/11 scoliosis
CPS, complex partial seizures; CYTO, cytogenetic abnormality; FTCS, focal tonic-clonic seizures; GER, gastro-oesophageal reflux;
GTCS, generalised tonic-clonic seizures; OFC, occipitofrontal circumference.
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Homozygous Foxg1e/e mutants die at birth with a dramatic
reduction in the size of the cerebral hemispheres affecting
ventral more severely than dorsal structures, and depletion of
neural progenitor pools.8 30 32e35 The cortical plate is poorly
organised with loss of layer-speciﬁc markers, and appears rela-
tively thick in lateral cortical regions as a result of accelerated
neuronal differentiation (see ﬁgure 1 in Hanashima et al33).
Heterozygous Foxg1+/e (especially Foxg1+/cre) mutants have
less severe developmental defects including reduced volumes of
the cerebral cortex, striatum and hippocampus, and thin cortex
due to reduced thickness of the superﬁcial layers (IIeIII) of the
cortex. The latter results from loss of neuron generating inter-
mediate progenitor cells duringmid and late corticogenesis and, to
a lesser extent, from a prolonged cell cycle in late corticogenesis.6 7
These data predict that humans with FOXG1 haploinsufﬁciency
should have microcephaly, thin cortex with abnormal cortical
cytoarchitecture (but with a thicker cortex possible in lateral
cortical regions), and cognitive plus behavioural defects.
FOXG1 mutations
Combining our series and prior reports, 18 intragenic sequence
changes of FOXG1 have been reported including 14 nulldsix
nonsense and eight frameshiftdand four missense mutations
(supplementary tables 1 and 2). The missense mutations
(p.F215L, p.N227K, p.S234P, and p.N253D) all affect evolution-
arily highly conserved amino acid residues in the forkhead
domain involved in DNA binding. One group hypothesised
that amino acid substitutions in functional domains of FOXG1
and late truncating mutations may lead to a milder phenotype
including typical and atypical Rett syndrome because the
resulting FOXG1 proteins may retain some functions, especially
their ability to bind corepressors.13 However, the p.Y400X and
p.S323fsX325 mutations, identiﬁed in patients with a severe
phenotype, leave one FOXG1 domain intact which interacts
with the Groucho corepressor family.36 Thus, missense as well
as clear loss-of-function mutations can have a severe impact on
FOXG1 function, suggesting that other factors may modulate
the phenotypic outcome.
The recurrent c.460dupG mutation causing duplication of
a guanine after seven subsequent guanines in FOXG1 was
identiﬁed twice in our patient cohort and in one reported
patient.10 These ﬁndings suggest that this guanine stretch may
be prone to replication errors and represent a mutational hot
spot in FOXG1.
We identiﬁed the 14q12 breakpoint in patient 1 about 265 kb
downstream of the FOXG1 gene. The ﬁnding of de novo FOXG1
mutations in patients with a developmental encephalopathy
overlapping Rett syndrome strongly suggests that altered
Table 2 Brain imaging data for patients with deletion 14q12 or FOXG1 mutations
This report N[11 Literature1e5 9e13 N[15
Simplified gyral pattern 11/11 SIMP 01/01 SIMP
Pachygyria, mild frontal 03/11 frontal pachygyria 00/02 frontal pachygyria
Reduced volume white matter (frontal) 11/11 reduced WM 04/04 reduced WM
Hypogenesis corpus callosum (frontal) 09/11 hypogenesis CC 09/09 hypogenesis CC
Agenesis corpus callosum (severe) 01/11 ACC with deletion 02/13 ACC
ACC, agenesis of corpus callosum; CC, corpus callosum; SIMP, simplified gyral pattern; WM, white matter.
Figure 4 Patients with FOXG1
mutations. Two patients with 14q12
deletions (top row, A, B) demonstrate
mild facial dysmorphism consisting of
round face with flat midface, low nasal
bridge, bulbous nasal tip, thin upper lip
and prominent ears. Four children with
regulatory (top row, C and bottom row,
D) or intragenic mutations (bottom row,
E, F) have normal facial appearance
except for mildly prominent ears. One
photo shows hand stereotypy (D), and
another shows striking esotropia (F).
The patient numbers and mutations are
shown at the bottom of each
photograph.
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expression of FOXG1 due to displacement of cis-regulatory
elements important for its spatial and temporal expression
caused the disease phenotype in patient 1. The 14q12 breakpoint
of a different de novo 2;14 translocation was mapped w5 kb
downstream of the FOXG1 gene.5 The authors postulated that
the breakpoint disrupted novel FOXG1 splice variants between
exons 3 and 4 with a brain speciﬁc expression pattern, repre-
sented by the EST (expressed sequence tag) sequence BX248251.
However, the non-coding RNA gene C14orf23 maps distal to
FOXG1 (ﬁgure 3A), and the reference sequence of this gene was
derived from BX248251, which suggests that the putative
FOXG1 exons 2e5 more likely represent exons of C14orf23. In
line with this, no mutations in these exons have yet been
reported.13 Thus, we suggest that both 2;14 translocations
resulted in removal of long range regulatory elements of FOXG1,
located in the gene desert between FOXG1 and PRKD1.
Further evidence supporting the existence of sequences regu-
lating FOXG1 expression comes from our identiﬁcation of
a w1 Mb microdeletion not covering FOXG1 in patient 4. The
phenotypes of both patients 1 and 4 are very similar to FOXG1
mutation positive individuals, suggesting that dysregulated
FOXG1 expressionmay be responsible for their clinical features. In
addition, two more patients with small overlapping micro-
deletions of 0.14e1.8 Mb that do not seem to include FOXG1have
been reported and are associated with a phenotype ﬁtting with
that of FOXG1mutation positive patients.3 Our in silico analysis
revealed two highly conserved non-coding elements of 1819 bp
and 1848 bp between FOXG1 and PRKD1 that drive expression of
a reporter gene speciﬁcally in the forebrain of transgenic mice
(http://enhancer.lbl.gov/frnt_page.shtml). Thus, we propose
that regulatory mutationsdthat is, displacement and deletion of
the two putative cis-regulatory elements by the translocation and
the w1-Mb microdeletion, respectivelydcause a phenotype
similar to that caused by mutations directly affecting FOXG1.
Nonetheless, the phenotype of patient 4 is less severe than our
other patients. This suggests disrupted function of a spatiotem-
porally speciﬁc subset of the normal expression pattern.37
The FOXG1 syndrome
We report the largest series of patients with FOXG1 mutations
to date. Analysis of our 11 patients and 15 patients from the
literature1e5 9e13 reveals a complex and consistent develop-
mental phenotype that affects many areas of neurologic and
behavioural function (thus classiﬁed as a developmental
encephalopathy). By recognising classic dyskinesias and a novel
and speciﬁc pattern of brain malformations in our cohort of
patients we also expand the phenotype.
The characteristic features of the FOXG1 syndrome include:
(1) moderate postnatal growth deﬁciency; (2) severe postnatal
microcephaly; (3) severe mental retardation with (4) absent or
minimal language development; (5) deﬁcient social interactions
including poor eye contact denoting a syndromic form of
autism; (6) combined stereotypies and frank dyskinesias with
mixed features of athetosis, chorea and dystonia; (7) epilepsy;
(8) poor sleep patterns; (9) irritability especially in infancy; (10)
excessive episodes of crying; (11) recurrent aspiration; and (12)
frequent gastro-oesophageal reﬂux. While a few prior reports
described developmental regression in some children, the history
was vague as it was in two of our patients, leading us to exclude
this as a diagnostic feature. Several other clinical problems were
reported in a few patients, such as clubfeet, scoliosis, bruxism,
and constipation.
Brain imaging studies reveal frontal predominant simpliﬁed
gyral pattern, reduced white matter volume and callosal
hypogenesis, with variable appearance of mild frontal pachy-
gyria. Complete agenesis of the corpus callosum was observed in
only 3/24 patients overall, but in 2/7 patients with deletion
14q12, which suggests modifying genes in the region. Considering
the thin cortex observed in the Foxg1+/e mouse, it seems possible
that the mild pachygyria seen in a few patients is an artefact
resulting from image averaging of the cortical ribbon due to the
very thin frontal white matter. However, the Foxg1e/e mouse has
a dysplastic cortex, so we prefer to reserve judgement on this
issue until higher resolution brain scans or human brain tissue
become available.
FOXG1 genotypeephenotype analysis
The number of reported mutations is now large enough to begin
genotypeephenotype correlation. Combining our data and
several literature reports, the core phenotype is seen in individ-
uals with mutations causing protein truncation and in some
with missense and other mutations. Patients with large dele-
tions of 14q12 that include FOXG1 and other genes may have
more severe phenotypes, adding complete agenesis of the corpus
callosum and mild facial dysmorphism to the core phenotype.
Also, some patients with missense or putative regulatory
mutations appear to have less severe phenotypes. Combining
our series and literature reports, only 6/23 patients were able to
sit, and four of the six had less severe mutations including a late
truncation (p.S323fsX325), a regulatory mutation (deletion
34 kb downstream of FOXG1 in patient 4), and two missense
mutations (p.F215L, and p.N253D in patient 5). Only 2/26
patients learned to walk and both had less severe mutations
including one late truncation (p.Y400X) and the same missense
mutation (patient 5 with p.N253D).
The association between FOXG1 and developmental abnor-
malities in humans is further supported by recent reports of
duplication 14q12 including the FOXG1 in eight patients.14 15
The phenotype resembles the FOXG1 haploinsufﬁciency
syndrome described above, including severe developmental
delay, mental retardation and absent or minimal language in 8/8,
seizures in 5/8, hypotonia in 2/8, stereotyped behaviour espe-
cially perseverative hand movements in at least 4/8, and inap-
propriate laughing and sleep disturbance in at least 1/8 patients.
However, the seizures were more severe, with typical infantile
spasms reported in 4/8 patients. Other differentiating features
include normal head circumference by age 1e3 years in 7/8
patients, and walking in at least 3/8 patients. Based on limited
data, brain imaging features appear to be similar but less severe
including subtle hypogenesis of the corpus callosum in at least
three patients, and reduced white matter volume in at least two
patients (this interpretation is based partly on our interpretation
of ﬁgure 2 in Brunetti-Pierri et al14).
The FOXG1 syndrome or congenital Rett syndrome variant
This disorder was ﬁrst described as a congenital variant of Rett
syndrome. While many features do overlap with Rett syndrome,
several features beyond the congenital onset differ as well. For
example, the presence of true dyskinesias and brain imaging
abnormalities, as well as the lack of regression and lack of
respiratory arrhythmia, differ from classic Rett syndrome. We
believe that the combination of developmental and brain
imaging features observed in individuals with FOXG1mutations
are sufﬁciently distinct to allow clinical recognition of this
disorder, which we therefore prefer to designate simply as the
FOXG1 syndrome.
Further, the phenotypic overlap with other complex devel-
opmental syndromes extends far beyond similarity to Rett
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syndrome to include at least nine different syndromes and genes:
Angelman syndrome, classic Rett and other MECP2 associated
syndromes, the ARX, CDKL5, CNTNAP2, NRXN1, SLC9A6, and
TCF4 associated syndromes, and maternal isodicentric and
duplication 15q11.2q13 syndromes.16 18 21 22 38e42 Most are
single gene disorders, and all present with a wide spectrum of
cognitive, social, affective, autonomic and motor deﬁcits, as well
as epilepsy. Considering the increasing number and phenotypic
heterogeneity of these disorders, we have begun to use the term
complex or mixed ‘developmental encephalopathies’ to refer to
the group as a whole.
In conclusion, we present the ﬁrst evidence for mutations of
cis-regulatory elements required for spatially, temporally, and
quantitatively correct activity of FOXG1 in patients with the
same phenotype as individuals with intragenic FOXG1 lesions,
as well as several novel intragenic mutations. The speciﬁc
pattern of developmental features and brain malformations
observed in individuals with FOXG1 mutations should allow
clinical recognition of the FOXG1 syndrome and prompt genetic
testing of the gene.
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